Letter: the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy - authors' reply

Aliment Pharmacol Ther. 2017 Oct;46(7):703-704. doi: 10.1111/apt.14259.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents
  • Hepatitis B Surface Antigens*
  • Hepatitis B virus*
  • Humans
  • Virus Activation / drug effects

Substances

  • Antiviral Agents
  • Hepatitis B Surface Antigens